Regular ArticleIntraoperative Autologous Transfusion during Elective Infrarenal Aortic Reconstruction
References (0)
Cited by (18)
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2018, Journal of Vascular SurgeryCitation Excerpt :Although preoperative autologous blood donation avoids disease transmission and transfusion reaction as well as stimulates erythropoiesis, limitations include limited availability of blood donation, increased expense, and potential waste of nonused blood.565 Intraoperative cell salvage assists in blood conservation, has been recommended if large blood loss is anticipated, and may be helpful where concerns of the safety of banked blood exist.566-568 A prospective randomized trial of cell salvage in elective cardiac surgery did not lead to a reduction in exposure to allogeneic blood but did reduce the number of transfused units.569
Surgical Treatment of Abdominal Aortic Aneurysms
2013, Vascular Medicine: A Companion to Braunwald's Heart Disease: Second EditionThe role of cell salvage autotransfusion in abdominal aortic aneurysm surgery
2011, European Journal of Vascular and Endovascular SurgeryCitation Excerpt :None of the three studies reported above mentioned the use of blood products other than red cells. Five uncontrolled studies have recorded blood-product use with routine use of a CS with very different outcomes (Table 1).39–43 Kelly-Patteson et al. prospectively studied 40 patients undergoing elective infrarenal AAA repairs by a single surgeon with a transfusion threshold of Hb < 8 g dl−1.39
Intraoperative Use of Cell Saver on Patients Undergoing Open Abdominal Aortic Aneurysm Surgical Repair: A Greek Hospital Experience
2011, Journal of Perianesthesia NursingCitation Excerpt :IAT is actualized through the use of cell saver machines built for the purpose of decreasing allogenic transfusions, conserving blood bank resources, and reducing the risk of transfusion-associated infections. Furthermore, these devices provide a readily available source of blood during excessive bleeding.7–9 Divergent views exist on the cost-effectiveness of IAT.
Recombinant Activated Factor VII: A Solution to Refractory Haemorrhage in Vascular Surgery?
2008, European Journal of Vascular and Endovascular SurgeryCitation Excerpt :Excessive blood loss, and blood product transfusion requirements, are two key independent predictors of outcome in major vascular surgery patients.3,4 Research into haemorrhage reduction in this setting includes the use of antifibrinolytics (e.g. aprotinin) and intra-operative autologous transfusion devices.5–7 However these have met with limited results.